MDEV vs. ARKG
Compare and contrast key facts about First Trust Indxx Medical Devices ETF (MDEV) and ARK Genomic Revolution Multi-Sector ETF (ARKG).
MDEV and ARKG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. MDEV is a passively managed fund by First Trust that tracks the performance of the Indxx Global Medical Equipment Index. It was launched on Jun 22, 2021. ARKG is an actively managed fund by ARK. It was launched on Oct 31, 2014.
Performance
MDEV vs. ARKG - Performance Comparison
Loading graphics...
MDEV vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
MDEV First Trust Indxx Medical Devices ETF | -9.41% | 2.00% | 1.79% | 7.55% | -28.59% | 4.16% |
ARKG ARK Genomic Revolution Multi-Sector ETF | -8.80% | 23.04% | -28.24% | 16.22% | -53.90% | -30.38% |
Returns By Period
In the year-to-date period, MDEV achieves a -9.41% return, which is significantly lower than ARKG's -8.80% return.
MDEV
- 1D
- 2.23%
- 1M
- -9.05%
- YTD
- -9.41%
- 6M
- -4.81%
- 1Y
- -5.71%
- 3Y*
- -2.27%
- 5Y*
- —
- 10Y*
- —
ARKG
- 1D
- 6.45%
- 1M
- -11.87%
- YTD
- -8.80%
- 6M
- -4.86%
- 1Y
- 27.26%
- 3Y*
- -4.22%
- 5Y*
- -21.56%
- 10Y*
- 4.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
MDEV vs. ARKG - Expense Ratio Comparison
MDEV has a 0.70% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Return for Risk
MDEV vs. ARKG — Risk / Return Rank
MDEV
ARKG
MDEV vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MDEV | ARKG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.30 | 0.61 | -0.91 |
Sortino ratioReturn per unit of downside risk | -0.31 | 1.19 | -1.50 |
Omega ratioGain probability vs. loss probability | 0.96 | 1.13 | -0.17 |
Calmar ratioReturn relative to maximum drawdown | -0.37 | 0.82 | -1.19 |
Martin ratioReturn relative to average drawdown | -1.17 | 2.22 | -3.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MDEV | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.30 | 0.61 | -0.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.48 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.11 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | 0.08 | -0.38 |
Correlation
The correlation between MDEV and ARKG is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
MDEV vs. ARKG - Dividend Comparison
Neither MDEV nor ARKG has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Drawdowns
MDEV vs. ARKG - Drawdown Comparison
The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for MDEV and ARKG.
Loading graphics...
Drawdown Indicators
| MDEV | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.34% | -83.59% | +41.25% |
Max Drawdown (1Y)Largest decline over 1 year | -14.88% | -27.51% | +12.63% |
Max Drawdown (5Y)Largest decline over 5 years | — | -80.18% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -32.20% | -76.36% | +44.16% |
Average DrawdownAverage peak-to-trough decline | -25.39% | -35.30% | +9.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 10.16% | -5.50% |
Volatility
MDEV vs. ARKG - Volatility Comparison
The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 5.67%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 13.28%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MDEV | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.67% | 13.28% | -7.61% |
Volatility (6M)Calculated over the trailing 6-month period | 10.88% | 31.86% | -20.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.99% | 44.94% | -25.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.00% | 45.37% | -26.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.00% | 40.94% | -21.94% |